University of Virginia Health System

Research in Transition

Every day we maintain our momentum in translating academic research into high-quality medical care. Our research interests are focused on areas that will enhance the well-being of transplant patients, including new methods in critical care:

• studies of infectious disease and immunology (especially Hepatitis B and C)
• advances in adult and pediatric transplantation
• studies of cytokine response
• analysis of biliary tract complications
• prevention of sepsis-induced ARDS (Adult Respiratory Distress Syndrome)
• long-term outcome evaluations

We continue to pace our clinical practice with research devoted to comparing kidney donor-related and non-related outcomes and the post-surgical problems of bone disease and heart attacks.

Hepatitis B and C: Progress in a Critical Area

Our hepatitis research programs are among the most comprehensive in the nation and have received international recognition as well. Those studies include investigations of persistent chronic hepatitis and viral hepatitis B and C. UVa's ongoing research in hepatitis B includes developing methods of optimizing the delivery of immune globulin and augmenting this therapy with new anti-viral agents directed against the hepatitis B virus. Researchers at UVa are also studying the hepatitis C virus subtypes, as well as the application of techniques that have been successful with the prevention of hepatitis B to patients transplanted for hepatitis C.

The Strickler Tradition: Leadership in Research

Combined with an ongoing program of drug studies, the Charles O. Strickler Transplant Center remains a leader in organ transplant research in the United States and throughout the world.